Net Loss Per Share

12 Months Ended

Dec. 31, 2015

18. Net Loss Per Share

The Company computes basic and diluted loss per share using a methodology that gives effect to the impact of outstanding participating securities (the “two-class method”). As the years ended December 31, 2015 and 2014 resulted in net losses, there is no income allocation required under the two-class method or dilution attributed to weighted-average shares outstanding in the calculation of diluted loss per share.

The following potentially dilutive securities outstanding, prior to the use of the treasury stock method, have been excluded from the computation of diluted weighted-average shares outstanding for the years ended December 31, 2015 and 2014, as they would be anti-dilutive. In addition, Second Installment Shares issuable to former Bioceros shareholders with a value of $5,000 to be issued in March 2016 have been excluded from the computation of basic and diluted weighted-average shares outstanding for the year ended December 31, 2015 (Note 5).


	As of December 31,
	2015	2014
Options to purchase common stock	3,613,427	1,652,882
Settlement of loan agreement	248,093	248,093
Nonvested restricted stock units	124,442	—
Warrants to purchase common stock	92,892	93,040
Employee stock purchase plan	2,871	—
Nonvested restricted stock awards	—	13,259